LOGIN
Enoxaparin superior to warfarin in prevention of venous thromboembolism after primary TKA
September 2014
Enoxaparin superior to warfarin in prevention of venous thromboembolism after primary TKA
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin
J Bone Joint Surg Am. 2001 Jun;83-A(6):900-6Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
349 patients undergoing knee arthroplasty were randomized to receive thromboprophylaxis with enoxaparin or warfarin postoperatively. Patients were assessed for venous thromboembolism defined as deep vein thrombosis and pulmonary vein thrombosis. Enoxaparin was significantly more effective than adjusted‐dose warfarin in reducing the occurrence of asymptomatic venous thromboembolism, including proxi...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.